Showing results (3211-3220 of 11,761) with videos related to

Sort By:
Pageof 1,177
European Heart Journal|March 10, 2019
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarctionLorenz Räber, Kyohei Yamaji, Henning Kelbæk, et al.
European Heart Journal|March 13, 2019
Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functionsJos Lelieveld, Klaus Klingmüller, Andrea Pozzer, et al.
European Heart Journal|May 1, 1988
Prolongation of the QT interval as an indicator of risk of a cardiac eventD E Ward
European Heart Journal|February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trialJonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
European Heart Journal|November 20, 2018
Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage deathTom T P Seijkens, Kikkie Poels, Svenja Meiler, et al.
European Heart Journal|November 20, 2018
A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomesFredrik Holmqvist, Milos Kesek, Anders Englund, et al.
European Heart Journal|January 1, 1988
Effect of vasodilator therapy on mortality in chronic congestive heart failureJ N Cohn
European Heart Journal|November 22, 2018
Association of hypertension cut-off values with 10-year cardiovascular mortality and clinical consequences: a real-world perspective from the prospective MONICA/KORA studySeryan Atasoy, Hamimatunnisa Johar, Annette Peters, et al.
European Heart Journal|November 22, 2018
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)David H Birnie, Jeff S Healey, George A Wells, et al.
European Heart Journal|February 24, 2021
All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort StudyJawad H Butt, Emil L Fosbøl, Thomas A Gerds, et al.
Pageof 1,177